Innovative, high-quality medical education for clinicians in cardiology and other specialties.
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
Steven Fishbane, MD
Maurizio Gallieni, MD
Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
Chee Kay Cheung, MBChB, MRCP, PhD
Claudia Seikrit, MD
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
Ellie Kelepouris, MD, FACP, FAHA
Nihar R. Desai, MD, MPH
The Potassium Shift: Individualizing Hyperkalemia Management With Modern Oral Potassium Binders
James Burton, DM, FRCP
Pauline A. Swift, PhD
Advancing Lipid Care: CETP Inhibition and Overcoming Inertia in Modern ASCVD Management
Christie Ballantyne, MD
Erin Michos
Philip Scheltens, MD, PhD
Lipids and the Brain: Extending Cardiovascular Risk Reduction to Neurodegenerative Disease
Beyond LDL-C: Genetic Drivers of Residual Risk in ASCVD
The Edema Question: Selecting a Potassium Binder in Patients With HF or Congestion
CKD, Diabetes, and Albuminuria: Keeping Kidney-Protective Therapy on Board Despite Hyperkalemia
Differentiating Oral Potassium Binders: Mechanism, Onset, and Sodium Load
Hyperkalemia as a Barrier to GDMT: Why “Stopping GDMT” Is Often the Wrong Reflex
Potassium Binders to Optimize GDMT Therapy in HFrEF